These findings are interesting in light of published data indicating that the elevated expression of CD36, VLDLR and FABP4 are associated with aggressive cancers and metastasis phenotypes and this has been correlated with increased uptake of exogenous lipids from the tumor microenvironment44–49. Here, CD36 is linked to cancer.